Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 117

Daily deal net: September 1, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Sep 1, 2021

Plaid plays to get Emotion Tech

Customer engagement management technology provider Plaid has become the major shareholder of a portfolio company that runs a similar service.

Sep 1, 2021

Zeekr sees its way to $500m

Bilibili, CATL and Intel were among the investors that have backed the smart EV developer’s pre-series A round, valuing the Geely spinoff at $9bn.

Aug 31, 2021

Daily deal net: August 31, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 31, 2021

Neural Galaxy taps into $77m series A

Harvard and MIT-linked Neural Galaxy has picked up $77m in a series A round led by existing shareholder 3E Bioventures.

Aug 31, 2021

SenseTime feels its way toward public markets

Alibaba, Qualcomm, SoftBank, Suning and Dalian Wanda are among the investors that could exit the AI-equipped machine vision technology developer, most recently valued at $12bn.

Aug 31, 2021

Doctor Anywhere gets administered series C funding

Novo and Philips Venture have joined existing investor IHH Healthcare in a $65.7m series C round for healthcare booking platform developer Doctor Anywhere.

Aug 31, 2021

Daily Deal Round Up: August 27, 2021

Opt's Bonds Investment Group led interior design sharing platform RoomClip's series E round in addition to online learning platform developer Schoo's series D.

Aug 27, 2021

Daily deal net: August 27, 2021

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aug 27, 2021

Genuine Biotech gets real with $100m

Shanghai Desano Pharmaceuticals has contributed to a series B round for the antiviral, cancer and cardiovascular drug developer, which is seeking to list in Hong Kong.

Aug 27, 2021
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here